ESG News For Kenvue Inc

At Kenvue, we recognize that people’s health is deeply interconnected with the health of our planet. Therefore, as a company singularly focused on consumer health, sustainability becomes a key element of how we do business and serve our Purpose.

At Kenvue, we learn, test, partner and optimize to bring real solutions into communities, homes and consumers’ hands. Using cutting-edge science and technology, we work diligently to earn people’s trust every day.

Having allergies can be frustrating, whether they’re making your eyes itch, your nose run, or a combination of symptoms. Thankfully, this Kenvue brand is an allergy medication grounded in pioneering research and science, designed to help relieve your allergy symptoms.

Company reports reduction of operational emissions by 37%, expanded use of renewable electricity to 72% and launch of multiple packaging innovations across portfolio

Kenvue announced its global community engagement efforts in celebration of Kenvue Cares Week, the company’s signature annual volunteer initiative part of its Healthy Lives Mission. Kenvue Cares Week is a testament to the strong Kenvue commitment to advance well-being.

First Task Force on Climate-related Financial Disclosures (TCFD) report enhances transparency and accountabilityCompany advances sustainability across its products, operations and value chain as part of its Healthy Lives MissionProgress includes reducing Scope 1 and 2 greenhouse gas emissions1, 2, 3 by 26% since 2020 and increasing renewable electricity4 usage to 65% of its electricity usage

Kenvue Inc. (NYSE: KVUE) (“Kenvue” or the “Company”), the maker of iconic brands such as Aveeno®, Listerine®, Neutrogena® and Tylenol®, is advancing progress toward the climate change goals outlined in its Healthy Lives Mission environmental, social and governance strategy

Kenvue is advancing its commitment to educating adults and youth about the importance of practicing safe skin care and overall skin health.

Maker of iconic brands such as Neutrogena®, Listerine®, Aveeno® and Tylenol® shares progress on its Environmental, Social and Governance goals in first year as an independent company.

Kenvue Inc. (NYSE: KVUE) (“Kenvue” or the “Company”), the world’s largest pure-play consumer health company by revenue, today released its first-ever Healthy Lives Mission Report and shared how the Company advanced the well-being of both people and planet in 2023.

Kenvue Inc. (NYSE: KVUE) (“Kenvue” or the “Company”), the world’s largest pure-play consumer health company by revenue, today announced that its near-term greenhouse gas emissions (GHG) reduction targets have been validated by the Science Based Targets initiative (SBTi).

Support Water Professionals by Following Tips to Help Prevent Home & Sewer Clogs